SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Moleculin Biotech Q3 Net Loss Narrows 74% to $6.49 Million

Moleculin Biotech Q3 Net Loss Narrows 74% to $6.49 Million Moleculin Biotech’s third-quarter 202

MBRX

Related stories